Acticor Biotech
Acticor Biotech
Description
Acticor Biotech is a clinical-stage biopharmaceutical company spun out of research by the French National Institute for Health and Medical Research (INSERM). Acticor Biotech is developing an innovative drug for the treatment of the acute phase of ischaemic stroke and other cardiovascular emergencies.
Acticor Biotech
Address
INSERM U1148 Hopital Bichat 46 rue Henri Huchard 75018 Paris
Paris, France
Paris, France
Contact
Description
Acticor Biotech is a clinical-stage biopharmaceutical company spun out of research by the French National Institute for Health and Medical Research (INSERM). Acticor Biotech is developing an innovative drug for the treatment of the acute phase of ischaemic stroke and other cardiovascular emergencies.
Matchmaking
Connect with Acticor Biotech
This entity is yours?
Update informationPosition on the value chain
With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.
Bio-resources and biobanking
- Cells, tissues and humanized xeno-organs
- Biosamples
- Viral, phage or bacterial specimen
Identification of biotherapies
- Target identification
- Target validation
- Screening
Drug design
- Drug assessment
- Drug engineering
- In vitro preclinical studies
Clinical validation
- Clinical trials
- In vivo preclinical validation
- Pre-industrial scale production
Production
- Upstream processes
- Downstream processes
- Quality control
Market access
- CE mark / market authorisation
- Payment / Reimbursement
- Care pathways